4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like iTeos Therapeutics Appoints As Vice President, Corporate Development June 28, 2017 Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results February 28, 2017 Filings Reveal Founder & CEO Buy Adds $570K to Retractable Tech Stake August 30, 2017
Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results February 28, 2017
